Загрузка...
Developmental therapeutics for inflammatory breast cancer: Biology and translational directions
Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer, which accounts for approximately 3% of cases of breast malignancies. Diagnosis relies largely on its clinical presentation, and despite a characteristic phenotype, underlying molecular mechanisms are poorly understood....
Сохранить в:
Опубликовано в: : | Oncotarget |
---|---|
Главные авторы: | , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Impact Journals LLC
2016
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5355355/ https://ncbi.nlm.nih.gov/pubmed/27926493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13778 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|